FDA Approves laViv, The only personalized aesthetic cell therapy anti-wrinkle drug approved by the FDA

June, 2011 Fibrocell Science Press Release — Fibrocell Science, Inc., a cell therapy company focused on the development of autologous (personalized) cell therapies for aesthetic, medical and scientific applications, announced today that the U.S. Food and Drug Administration (FDA) approved … Continue reading